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Biologic monitoring (i.e., biomonitoring) is
used to assess human exposures to environ-
mental and workplace chemicals. The most
commonly used matrices for biomonitoring
are blood (and its components, e.g., serum
and plasma) and urine. The average blood vol-
ume of an individual changes an average of
80 mL/kg body weight (Guyton and Hall
2000) and remains relatively constant for a
healthy individual who maintains a given body
weight; thus, changes in blood concentrations
of selected environmental and workplace
chemicals in individuals or populations can be
readily evaluated. For example, in the Third
National Health and Nutrition Examination
Survey (NHANES III) (Brody et al. 1994),
blood lead concentrations demonstrated
the decline in the concentrations of lead in
the U.S. population between the Second
NHANES (NHANES II), 1976–1980, and
the first phase of NHANES III, 1988–1991
(Pirkle et al. 1994). Blood has also been used
to evaluate exposures to lipophilic compounds,
such as polychlorinated dibenzo-p-dioxins,
polychlorinated biphenyls, and organochlorine
insecticides. These chemicals are reported in
blood and serum based on their lipid content,
which varies among individuals and within an
individual, especially after eating. Adjusting
based upon lipid content allows direct com-
parisons of their concentrations within and
among individuals, regardless of the amount of
lipid in the blood, and also comparisons
among various biologic matrices, such as blood
and adipose tissue (Phillips et al. 1989).
Urine also is a widely used matrix for bio-
monitoring, especially for nonpersistent chemi-
cals (i.e., chemicals that have short biologic
half-lives), such as some current-use pesticides,
metals, and drugs. One of the major advantages
of using urine in biomonitoring is its ease of col-
lection for spot or grab (untimed) urine samples
but not for 24-hr urine voids, because 24-hr col-
lection can be cumbersome, often resulting in
improper or incomplete collection. Therefore,
spot urine samples, whether ﬁrst-morning voids
or “convenience” samples, are generally used for
biomonitoring. The major disadvantages of spot
urine samples include the variability in the vol-
ume of urine and the concentrations of endoge-
nous and exogenous chemicals from void to
void. How to best adjust the urinary concentra-
tions of environmental chemicals in a manner
analogous to the adjustment of the concentra-
tions of lipophilic chemicals in blood samples
remains a subject of research.
Variations in urinary analyte concentra-
tions from changing water content in urine
have been eliminated using urinary excretion
rate (UER) calculations (Rigas et al. 2001). To
calculate the UER, the metabolite concentra-
tion in urine is multiplied by the volume of the
void and then divided by the duration of time
the void was accumulating in the bladder. This
model assumes that the entire bladder is emp-
tied with each void and that the entire sam-
pling void volume is known. Because this is
based on the mass in the sample, variability in
urine concentrations from urine dilution is
removed, particularly for analytes where the
rate of excretion varies with the urine flow
(Boeniger et al. 1993). However, because the
void volume and times of previous and current
voids are required, this approach is often not
practical for epidemiologic studies, especially
those studies involving young children or large
population groups.
Urinary creatinine concentrations, speciﬁc
gravity, and osmolality are common methods
for adjusting dilution and for determining
whether a spot urine sample is valid for assess-
ing chemical exposures. The most widely used
method is creatinine adjustment that involves
dividing the analyte concentration (micrograms
analyte per liter urine) by the creatinine con-
centration (grams creatinine per liter urine).
Analyte results are then reported as weight of
analyte per gram of creatinine (micrograms
analyte per gram creatinine).
Many studies have documented that
creatinine-adjusted urinary metabolite concen-
trations correlate better with blood, serum, or
plasma concentrations of the parent chemical
than the unadjusted concentrations, suggesting
that creatinine-adjusted analyte concentrations
may serve as good surrogates for size-related
dose (Cline et al. 1989; Hill et al. 1995a;
Shealy et al. 1997; To-Figueras et al. 1997).
However, these studies typically self-correct
for size variation because each data pair is
from a single individual. Thus, children, who
have blood volumes that are proportionately
smaller (80 mL less per kilogram body
Address correspondence to D.B. Barr, Centers for
Disease Control and Prevention, 4770 Buford Hwy,
Mailstop F17, Atlanta, GA 30341 USA. Telephone:
(770) 488-7886. Fax: (770) 488-0142. E-mail:
dbarr@cdc.gov
We thank the National Center for Health Statistics
for their thorough review and thoughtful input into
this article.
The authors declare they have no competing
ﬁnancial interests.
Received 18 June 2004; accepted 23 September 2004.
Biologic monitoring (i.e., biomonitoring) is used to assess human exposures to environmental and
workplace chemicals. Urinary biomonitoring data typically are adjusted to a constant creatinine
concentration to correct for variable dilutions among spot samples. Traditionally, this approach has
been used in population groups without much diversity. The inclusion of multiple demographic
groups in studies using biomonitoring for exposure assessment has increased the variability in the
urinary creatinine levels in these study populations. Our objectives were to document the normal
range of urinary creatinine concentrations among various demographic groups, evaluate the impact
that variations in creatinine concentrations can have on classifying exposure status of individuals in
epidemiologic studies, and recommend an approach using multiple regression to adjust for varia-
tions in creatinine in multivariate analyses. We performed a weighted multivariate analysis of uri-
nary creatinine concentrations in 22,245 participants of the Third National Health and Nutrition
Examination Survey (1988–1994) and established reference ranges (10th–90th percentiles) for each
demographic and age category. Signiﬁcant predictors of urinary creatinine concentration included
age group, sex, race/ethnicity, body mass index, and fat-free mass. Time of day that urine samples
were collected made a small but statistically signiﬁcant difference in creatinine concentrations. For
an individual, the creatinine-adjusted concentration of an analyte should be compared with a “ref-
erence” range derived from persons in a similar demographic group (e.g., children with children,
adults with adults). For multiple regression analysis of population groups, we recommend that the
analyte concentration (unadjusted for creatinine) should be included in the analysis with urinary
creatinine added as a separate independent variable. This approach allows the urinary analyte con-
centration to be appropriately adjusted for urinary creatinine and the statistical signiﬁcance of other
variables in the model to be independent of effects of creatinine concentration. Key words: biomoni-
toring, creatinine, creatinine adjustment, urine. Environ Health Perspect 113:192–200 (2005).
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tions of a chemical after the absorption of the
same amount of chemical after an exposure
compared with adults with an identical expo-
sure. Similarly, their lower urinary creatinine
concentrations would increase the creatinine-
adjusted urine concentration of the metabo-
lite compared with that of an adult with an
identical exposure. Therefore, the paired
urine and blood values from children and
adults can be easily used to determine the
relationship between matrices within an indi-
vidual, but this does not necessarily mean that
the creatinine-adjusted metabolite concentra-
tions can be used to accurately compare expo-
sures among the study participants.
Creatinine concentrations also are used to
determine whether the spot urinary sample is
valid. The guidelines of the World Health
Organization (WHO) for valid urine samples
for occupational monitoring often are used.
The WHO recommends that if a sample is too
dilute (creatinine concentration < 30 mg/dL) or
too concentrated (creatinine concentration
> 300 mg/dL), another urine void should be
collected (WHO 1996) and analyzed for creati-
nine and the target chemical. These guidelines
have been adopted for biomonitoring in the
U.S. workplace (Lauwerys and Hoet 1993).
The U.S. Department of Transportation
defines an acceptable urine specimen for the
screening of selected drugs of abuse as one that
has a creatinine concentration of ≥ 5 mg/dL
and a speciﬁc gravity of 1.001–1.020 (Barbanel
et al. 2002). Urine of “normal” persons would
be unlikely to be excluded using these criteria
(Barbanel et al. 2002).
Urine creatinine concentrations were used
to adjust the urinary concentrations of pesti-
cides and metabolites of pesticides and phtha-
lates in subsets of adults participating in
NHANES III. These “creatinine-corrected”
concentrations (micrograms analyte per gram
creatinine) were reported in addition to the
unadjusted concentrations in micrograms
analyte per liter urine (Blount et al. 2000; Hill
et al. 1995b). These reports also used the
WHO’s recommendation for exclusion of
samples, regardless of age (these were all
adults), sex, or race/ethnicity.
Because urinary creatinine concentrations
are so widely used to adjust or correct urinary
concentrations of environmental and work-
place chemicals or their metabolites, the for-
mation of urinary creatinine and the ways in
which various factors may affect its concentra-
tion are important to review. Creatinine is a
waste product formed by the spontaneous,
essentially irreversible dehydration of body
creatine and creatine phosphate from muscle
metabolism. A total of 94–98% of total crea-
tine is accumulated within skeletal muscle.
The rate of creatinine formation is fairly con-
stant, with approximately 2% of body creatine
converted to creatinine every 24 hr; this rate
decreases with age in adults.
Creatinine is cleared from the body
through the kidney primarily by glomerular
ﬁltration. However, 15–20% of the creatinine
in urine can occur by active secretion from the
blood through the renal tubules (Boeniger
et al. 1993). The rate of secretion can vary
substantially among persons because of various
genetic and biologic factors. Researchers have
found a high correlation between urinary
creatinine concentrations and muscle mass
(Edwards and Whyte 1959; Fuller and Rich
1982); higher urinary creatinine concen-
trations in men than in women (Bjornsson
1979; Turner and Cohn 1975); decreased uri-
nary creatinine concentrations in adults with
increasing age, probably because of a general
decline in muscularity and glomerular filtra-
tion rate (GFR) (Alessio et al. 1985; Drive and
McAlevy 1980); and seasonal variation in cre-
atinine concentrations in children (Freeman
et al. 1995; O’Rourke et al. 2000). In addi-
tion, persons with a high red meat intake have
a higher urinary creatinine concentration than
do those on a low-red-meat diet (Lykken et al.
1980). The effects of these factors and others
on urinary creatinine concentrations have
been reviewed (Boeniger et al. 1993).
Because of the relatively constant excretion
rate of creatinine into the urine (which makes
urinary creatinine concentration inversely pro-
portional to urine ﬂow rate), creatinine adjust-
ment has been used to normalize analyte
concentrations in spot samples for occupational
and environmental exposure monitoring. This
approach reportedly works well for individual
occupational exposure analysis (e.g., preshift
and postshift samples from the same person) if
the analyte measured behaves similarly to creati-
nine in the kidney (Boeniger et al. 1993).
However, if the analyte is excreted predomi-
nantly through passive secretion in the kidney,
the analyte secretion will vary with urine ﬂow
rate and creatinine adjustment would not cor-
rect for urine concentration/dilution.
Urinary creatinine concentration data have
been used to adjust urinary concentrations of
environmental and workplace chemicals, pri-
marily in adults. Thus, most of the published
urinary creatinine concentration data are for
adults. However, as more emphasis is placed
on children’s health issues and assessment of
their exposures to environmental contami-
nants, biomonitoring of younger populations
is also increasing (Needham and Sexton 2000;
O’Fallon et al. 2000).
Our study objectives were to document the
normal range of urinary creatinine concentra-
tions among various demographic groups, eval-
uate the inﬂuence demographic variations in
creatinine concentrations can have on biologic
monitoring measurements, and explore meth-
ods to appropriately adjust urinary analytes
using creatinine that take into account demo-
graphic differences in urinary creatinine levels.
In this article, we present urinary creatinine
concentrations in samples collected during
1988–1994 throughout the United States from
NHANES III participants. We describe the
distribution of urinary creatinine concentra-
tions within this population by age, sex, and
race/ethnicity for persons ≥ 6 years of age. We
also examine other factors that can affect uri-
nary creatinine concentrations, such as body
mass index (BMI), fat-free mass (FFM), and
health status: kidney function, hyperthyroidism,
hypertension, and diabetes (Boeniger et al.
1993). In addition, we compare urinary creati-
nine concentrations in urine samples collected
at three different times throughout the day
(morning, afternoon, and early evening).
Finally, we propose a multiple regression
approach to adjusting urinary analytes for dif-
ferences in creatinine concentration. This
information will greatly assist researchers, occu-
pational health physicians, risk assessors, public
health ofﬁcials, and other users of urinary bio-
monitoring data to better analyze and interpret
urinary biomonitoring measurements.
Materials and Methods
NHANES III, which was conducted by the
National Center for Health Statistics (NCHS)
of the Centers for Disease Control and
Prevention (CDC), was a 6-year survey during
1988–1994 designed to measure the health
and nutrition status of the civilian, noninstitu-
tionalized U.S. population ≥ 2 months of age.
National population estimates and estimates
for the three largest racial/ethnic subgroups in
the U.S. population (non-Hispanic white,
non-Hispanic black, and Mexican American)
can be derived from each of the two individual
3-year phases (1988–1991 and 1992–1994)
and from the full 6-year survey.
Sampling selection for NHANES III was
based on a complex multistage area probability
design. Children younger than 5 years, adults
≥ 60 years of age, non-Hispanic blacks, and
Mexican Americans were oversampled to
allow an adequate number of sample persons
in these demographic groups from which pop-
ulation-based estimates could be derived.
However, urine samples were not collected for
children < 6 years of age. Data were collected
through a household interview, and a stan-
dardized physical examination was conducted
in a mobile examination center. Urine speci-
mens for analyses, including those for measur-
ing creatinine concentrations, were collected
during this examination throughout the day.
Pre-examination procedures depended on the
age and health status of the individual. For
example, persons > 12 years of age were asked
to fast for 2–12 hr, depending on appointment
times, and persons with known diabetes or
< 12 years of age were asked to eat a normal
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information and medical histories of the survey
participants and their families were collected
during the household interviews. Details of the
sample design have been published (Ezzati et
al. 1992). The data set used in our analysis is a
part of the public release data set for NHANES
III (NCHS 2004a).
Laboratory methods. During the physical
examinations, urine specimens were collected,
stored cold (2–4°C) or frozen, and sent to
the Fairview University Medical Center
(Minneapolis, MN), where they were analyzed
for creatinine using an automated colorimetric
determination based on a modiﬁed Jaffe reac-
tion using a Beckman Synchron AS/ASTRA
clinical analyzer (Beckman Instruments, Brea,
CA) (Jaffe 1886). The laboratory and method
were certiﬁed according to guidelines set forth
in the Clinical Laboratory Improvement Act
and Amendment (1988).
Demographic covariates. Age was
reported at the time of the household inter-
view as the age in years at the last birthday.
Age categories used in our statistical analyses
were 6–11, 12–19, 20–29, 30–39, 40–49,
50–59, 60–69, and ≥ 70 years. A composite
racial/ethnic variable based on reported race
and ethnicity was created to define three
major racial/ethnic groups: non-Hispanic
black, non-Hispanic white, and Mexican
American. Persons who self-reported race as
none of the three major racial/ethnic groups
were included in the overall estimates but
excluded from analyses in which race/
ethnicity was the stratiﬁcation variable.
Health status deﬁnitions. The health status
of participants was considered in the data
analysis. All participants were tested for a vari-
ety of physical conditions that have been
reported to potentially affect urinary creati-
nine concentrations. Participants were not
screened for a given condition if they reported
having been previously informed by a physi-
cian as having one of the conditions. Clinical
parameters for determining the health status
of individuals are summarized in Table 1.
The GFR used for kidney function analy-
sis was calculated using the equation derived
from the Modification of Diet in Renal
Disease (MDRD) study (Coresh et al 2002,
2003; Levey et al. 2003), in which serum
creatinine, age, sex, and race were used.
Serum creatinine measurements for the
MDRD study and the NHANES III study
were performed in different laboratories, and
a laboratory bias was observed (Coresh et al.
2002). Thus, serum creatinine values in the
NHANES III data set were calibrated to be
more comparable with the laboratory data
obtained in the MDRD study by subtracting
0.23 mg/dL from each value (Coresh et al.
2002, 2003). For our analysis, we considered
persons to have kidney dysfunction if their
GFR was < 60 mL/min/1.73 m2, indicative of
moderately or severely decreased kidney func-
tion (Levey et al. 2003).
Statistical analysis. We analyzed data
using the NHANES III analytic guidelines
(NCHS 2004b) for sample size and coeffi-
cient of variation to ensure reliability of esti-
mates. Survey-specific sample weights were
used in statistical analyses. Arithmetic means,
selected percentiles of urinary creatinine con-
centrations, and their respective confidence
intervals were calculated using SAS release 8
(SAS Institute, Cary, NC) and the SUDAAN
(release 7.5.6; Research Triangle Institute
International, Research Triangle Park, NC)
Proc Descript procedure. SUDAAN incorpo-
rates the NHANES III sampling weights and
adjusts for the complex sample design of
NHANES III. Sample weights account for the
unequal probabilities of selection resulting
from the cluster design and the planned over-
sampling of certain subgroups. Oversampling
of children, the elderly, non-Hispanic blacks,
and Mexican Americans necessitated the use
of sampling weights in all analyses to produce
national estimates of prevalence and associated
variances. Because Proc Descript does not pro-
vide design effect estimates for distribution
percentiles, we multiplied the design effect
associated with a mean by 30 or 80 [i.e., the
NCHS-recommended sample size for estimat-
ing a proportion of 0.50 (n = 30) or a propor-
tion of 0.10 or 0.90 (n = 80) when the design
effect is 1.0 (NCHS 2004b)]. If this product
was larger than the actual sample size, we
determined that the percentile estimate should
not be reported. All distribution percentiles
reported met this criterion.
The collective data set of urinary creati-
nine values was slightly skewed toward higher
values; however, logarithmic transformation
did not improve the shape of the distribu-
tion. Because the results were only slightly
skewed and variance estimates obtained using
SUDAAN software were robust, we chose not
to transform the urinary creatinine results for
the analysis.
An analysis of covariance was used to cor-
rect for demographic covariates before com-
paring concentrations among demographic
groups and daily collection times. Statistical
signiﬁcance was set at p < 0.05.
Similar to the approach used by Wilder
et al. (unpublished data), we used multiple
linear regression models to study the influ-
ence of standard demographic variables on
urinary creatinine concentration and addi-
tional factors previously reported to affect uri-
nary creatinine concentrations. Nine variables
were evaluated, although all variables were not
used in the final model: race/ethnicity, sex,
age, BMI, FFM, diabetes status, hypertension
status, hyperthyroid disease status, and kidney
disease status. FFM was calculated using a sex-
and age-speciﬁc bioelectrical impedance analy-
sis equation reported by Deurenberg et al.
(1991). Height, weight, age, sex, and reac-
tance measurements (ohms at 50 kHz) were
used in the equation to derive individual esti-
mates of FFM. Reactance measurements were
available only for persons ≥ 12 years of age.
Our analysis comprised 22,245 valid crea-
tinine values in urine samples collected during
1988–1994. Although we did not perform a
thorough analysis of the rate of nonresponse
and its possible effects on our analyses, we did
evaluate the potential effects of differential
nonresponse using the method of Flegal et al.
(1991). We analyzed major demographic vari-
ables obtained from the interview data for per-
sons with urinary creatinine values and persons
without urinary creatinine values. For each
variable, we compared the observed mean uri-
nary creatinine level with the expected mean
value for persons in the interviewed sample
after we adjusted for that variable. The com-
parison assumed no statistical signiﬁcance from
differential nonresponse if the estimates were
within 10% of the expected means (Flegal
et al. 1991). We did not detect bias resulting
from differential nonresponse for any of the
previously listed variables.
Results
The weighted urinary creatinine arithmetic
means, medians, 10th and 90th percentiles,
and their respective upper and lower 95% con-
ﬁdence intervals (CIs) are shown in Table 2.
The data are shown both collectively and
divided into age, race/ethnicity, and sex cate-
gories. No data were excluded from the distri-
bution analysis. Non-Hispanic blacks had
signiﬁcantly greater concentrations of urinary
creatinine than did all other racial/ethnic
groups, across all age groups (p < 0.0006;
Figure 1). On average, blacks had 33.43 and
34.25 mg more creatinine per deciliter
of urine than did Mexican Americans and
Article | Barr et al.
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Table 1. Clinical parameters for designation of health status of individuals in NHANES III (1988–1994) survey.
Health status Clinical parameter
Diabetesa Blood glucose > 126 mg/dL after 8-hr fast
Hypertensionb Systolic value > 140 mm Hg or diastolic > 90 mm Hg
Hyperthyroidism Serum thyroid-stimulating hormone > 5 µU/mL
Kidney dysfunction Glomerular ﬁltration rate < 60 mL/min/1.73 m2
aAlso included individuals who were told by a physician that they had diabetes. bAlso included individuals who were told by
one physician two or more time or by two or more physicians that they were hypertensive. Systolic and diastolic measure-
ments were the average of three measurements.Article | U.S. urinary creatinine concentrations
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nnon-Hispanic whites, respectively. Adult (i.e.,
≥ 20 years of age) males had significantly
greater urinary creatinine than did adult
females (p < 0.0001).
The percentage of individuals in each
demographic group that had urinary creatinine
concentrations outside the WHO exclusionary
guidelines is shown in Table 3. Recently,
Wilder et al. (unpublished data) reported that
these exclusionary criteria should be re-evalu-
ated for urine samples taken from children. In
that study (410 children 1–8 years of age), 12%
of all children fell below the guideline value,
and 0% were too concentrated. Up to 8% of
the NHANES samples examined had urinary
creatinine concentrations < 30 mg/dL, whereas
< 3% had concentrations > 300 mg/dL.
Although these percentages differed for each
demographic category, more samples were con-
sidered “too dilute” than “too concentrated.”
The mean concentrations of urinary crea-
tinine stratiﬁed by collection time are shown
in Table 4. Creatinine concentrations were
statistically different for some of the collection
periods, although the differences were < 6%.
Morning voids typically yielded higher urinary
creatinine concentrations than did urine sam-
ples at other collection times. Urinary creati-
nine differed significantly between morning
and evening collections (p = 0.001); the differ-
ence was marginally signiﬁcant between morn-
ing and afternoon (p = 0.058) collections.
Afternoon and evening creatinine concentra-
tions did not differ significantly from one
another (p = 0.272).
We did not have the information to classify
the diabetic status or kidney function of persons
6–19 years of age; thus, we first limited our
multiple linear regression analysis to subjects
≥ 20 years of age to determine the effects of dia-
betes and kidney function on urinary creati-
nine. For subjects ≥ 20 years of age, statistically
signiﬁcant categorical independent variables in
the model included race/ethnicity, sex, diabetic
status, kidney function status, and age group.
The continuous independent variable BMI was
also a statistically signiﬁcant factor. There were
statistically significant interactions between
race and diabetic status (p = 0.0022), between
race and kidney function status (p = 0.0073),
between race and age group (p = 0.0028),
between sex and age group (p = 0.0260),
and between diabetic status and age group
(p = 0.0133). Hyperthyroidism, hypertension,
and FFM were not significant factors in the
model and thus were not included in the ﬁnal
model.
Participants with diabetes tended to have
lower urinary creatinine levels than did those
without diabetes, and the magnitude of the
decrease varied signiﬁcantly among the three
racial/ethnic groups studied and among the age
categories. For example, non-Hispanic black
participants with diabetes had urinary creati-
nine levels 34.2 mg/dL lower (p < 0.0001)
than those without diabetes in the same ethnic
group, whereas no signiﬁcant differences were
observed in the other racial/ethnic groups.
Similar variation was observed for persons
with diabetes in different age group categories.
For example, urinary creatinine levels for per-
sons with diabetes 30–39 years of age were
40.6 mg/dL lower (p = 0.011) than those with-
out diabetes in the same age group.
The effect of kidney dysfunction on uri-
nary creatinine concentration was not the same
across racial/ethnic groups. Non-Hispanic
whites with kidney dysfunction had urinary
creatinine levels 10.7 mg/dL (p = 0.0047)
higher than those without kidney disease,
whereas the levels for Mexican Americans with
kidney disease were 15.5 mg/dL (p = 0.0329)
lower than those without.
So that we could include children and
adolescents in our analyses, we next performed
multiple linear regression analyses that included
all ages. Subjects ≥ 20 years of age were only
included if they could be classiﬁed as not hav-
ing diabetes and as not having moderately or
severely decreased kidney function.
Coefﬁcients from the multiple linear regres-
sion model are presented in Table 5. The R2 of
the model was 0.175. Statistically signiﬁcant cat-
egorical independent variables in the model
included race/ethnicity, sex, and age group.
Neither hyperthyroidism nor hypertension was
a signiﬁcant factor in the model. The continu-
ous independent variable BMI was also a statisti-
cally signiﬁcant factor. Statistically signiﬁcant
interactions were observed between race and age
group (p = 0.0002) and between sex and age
group (p< 0.0001).
According to the model results, the effect of
age category on urinary creatinine concentra-
tions differed among each racial/ethnic group.
Among Mexican Americans, urinary creatinine
levels for 20- to 29-year-olds were 44.3 mg/dL
higher (p < 0.0001) than those for 50- to
59-year-olds. Among non-Hispanic whites, this
difference was 55.8 mg/dL (p < 0.0001), and
among non-Hispanic blacks, 57.5 mg/dL
(p < 0.0001).
BMI also was significantly related (p <
0.0001) to urinary creatinine concentrations.
According to the model results, every unit
increase in BMI was associated with a
1.30 mg/dL increase in urinary creatinine.
Thus, persons with a BMI at the 90th
percentile (31.37 kg/m2) would be expected
to have urinary creatinine levels about
8.6 mg/dL higher than persons of the same
demographic group but with a BMI at the
median (24.75 kg/m2). However, when FFM
is included in the model, it interacts strongly
with BMI. For example, at the median FFM
(2574.97 units), a one-unit increase in BMI
results in a 0.92-mg/dL increase in urinary
creatinine. At the 75th percentile FFM
(2692.15 units), a one-unit increase in BMI is
associated with a 0.5-mg/dL increase in uri-
nary creatinine. At the 25th percentile FFM
(2462.47 units), a one-unit increase in BMI is
associated with a 1.33-mg/dL increase in uri-
nary creatinine. Thus, at higher FFM, BMI
has a smaller effect on urinary creatinine.
Discussion
Biomonitoring of exposure is used in the work-
place to evaluate a person’s chemical exposure
during the workday and to provide some stan-
dard measure for allowable individual work-
place exposures. When timed urine excretion
(to determine UER) or 24-hr samples are not
collected, the chemical measurement is rou-
tinely adjusted using creatinine to correct for
urine concentration/dilution in spot samples.
For occupational monitoring, the WHO
has recommended exclusionary guidelines for
urinary creatinine concentrations to identify
individual samples that are invalid for chemical
analysis. The rationale behind these guidelines
is that urine samples with extremely low creati-
nine concentrations are too dilute and may
impair detection of low levels of toxicants,
whereas samples with extremely high creatinine
concentrations indicate dehydration, which
could have changed the kidney’s secretion,
excretion, and/or reabsorption of the target
chemical. Therefore, analysis of either dilute
or concentrated spot samples would not result
in an analyte concentration representative of
actual exposures. Typical statistical rules of
exclusion of outliers would exclude the upper
and lower 1 or 5% of the population. However,
our data indicate that in some demographic cat-
egories, almost no one would be excluded using
these criteria. In other demographic categories,
as many as 20% of the participants would be
excluded. These data support the findings
recently reported by Wilder et al. (unpublished
data). For example, essentially no Mexican-
American female adults ≥ 70 years of age had
urinary creatinine > 300 mg/dL. However, in
the same demographic group, about 19%
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Figure 1. Mean urinary creatinine concentrations
(mg/dL) for each sex and racial/ethnic group by
age group. of the samples would be excluded because
their urinary creatinine concentrations were
< 30 mg/dL.
The WHO guidelines may have been
established for occupational monitoring using
a workforce with less diversity than the
U.S. workforce. If only non-Hispanic white
males 20–60 years of age are considered,
approximately 10% of the samples would
have been excluded, 5% for each exclusionary
criterion. Among both sexes in this age range
or women alone, approximately 15% of sam-
ples would have been excluded, with the
majority (9–13%) excluded for being too
dilute. In the U.S. population as a whole,
samples from nearly 10 million women could
be excluded using criteria that were likely not
established using data from women. Clearly,
with the change in the composition of the
modern U.S. workforce to include women,
multiple racial/ethnic groups, and older work-
ers because of the increasing retirement age,
the guidelines for sample exclusion should be
re-evaluated to reflect the results shown in
Table 2. In addition, a special reconsideration,
or perhaps elimination, of the lower limit of
acceptable creatinine concentration should be
given. As analytical technology for measuring
environmental toxicants or their metabolites
in urine samples has dramatically improved
over the last several decades, driving the limits
of detection very low, detection of chemicals
in urine samples considered “dilute” is much
less likely to be an issue of concern. Rather,
intermittent or low-level exposures will likely
have a greater effect on the ability for a given
marker of exposure to be measured with cur-
rent analytical technology.
We observed a small but statistically sig-
niﬁcant increase in creatinine concentrations
in the morning compared with the afternoon
and evening. Although we have no informa-
tion suggesting the morning urine collections
in NHANES III were first morning voids,
our analyses appear consistent with the gen-
eral thought that urine from a first morning
void is more concentrated.
In the early 1980s, biomonitoring for
nonoccupational, environmental exposures
became an important exposure assessment
tool in epidemiologic studies evaluating envi-
ronmental exposure risks. In these studies,
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Table 4. Weighted mean urinary creatinine concentration (mg/dL) for each collection time frame during
the day.
Collection Mean creatinine Contrasted to Contrasted to Contrasted to
time frame No. (mg/dL) morning afternoon evening
Morning 10,621 133.5 NA p = 0.058 p = 0.001
Afternoon 7,190 128.6 p = 0.058 NA p = 0.27
Evening 4,434 126.1 p = 0.001 p = 0.27 NA
NA, not applicable. The concentrations were corrected for age, race/ethnicity, sex, and BMI. Each mean was contrasted to the
means of other collection time frames using an analysis of covariance test to determine whether they were statistically different.
Table 3. Percentage of each demographic group in NHANES III (1988–1994) whose urinary creatinine concentrations (mg/dL) fell outside the WHO guideline
range (i.e., < 30 mg/dL or > 300 mg/dL).
Race/ethnicity, All Male Female
age (years) No. < 30 mg/dL > 300 mg/dL No. < 30 mg/dL > 300 mg/dL No. < 30 mg/dL > 300 mg/dL
All
All 22,245 7.7 3.3 10,610 4.0 4.6 11,635 11 2.2
6–11 3,078 4.7 0.1 1,590 2.9 0.1 1,488 6.7 0.1
12–19 3,095 2.3 6.5 1,461 1.6 6.0 1,634 3.1 7.0
20–29 3,438 5.2 6.9 1,608 3.4 10 1,830 7.0 4.2
30–39 3,259 8.4 4.2 1,438 4.3 6.4 1,821 12 2.0
40–49 2,542 11 2.5 1,203 5.9 3.8 1,339 16 1.3
50–59 1,823 12 0.9 838 6.0 1.5 985 17 0.3
60–69 2,243 9.3 0.6 1,134 3.9 1.2 1,109 14 0.1
≥ 70 2,767 10 0.7 1,338 3.5 1.1 1,429 15 0.5
Non-Hispanic white
All 8,150 8.8 3.0 3,820 4.5 4.2 4,330 13 1.8
6–11 800 4.3 0.0 413 2.6 0.0 387 6.1 0.0
12–19 790 3.0 6.1 348 2.0 4.6 442 3.9 7.6
20–29 879 6.2 6.4 388 3.9 10 491 8.4 3.0
30–39 1,025 9.2 4.0 437 4.9 6.2 588 14 1.8
40–49 893 13 2.3 422 7.0 3.5 471 19 1.1
50–59 884 13 0.6 409 7.4 1.1 475 18 0.2
60–69 963 9.3 0.4 495 3.0 0.8 468 15 0.0
≥ 70 1,916 11 0.8 908 3.6 1.2 1,008 15 0.5
Non-Hispanic black
All 6,664 2.8 7.1 3,117 1.5 9.8 3,547 3.8 4.8
6–11 1,060 3.4 0.6 553 2.7 0.4 507 4.2 0.8
12–19 1,113 0.6 12 530 0.2 15 583 1.1 8.5
20–29 1,098 1.7 13 484 1.6 17 614 1.7 9.5
30–39 1,120 2.8 7.6 480 1.8 12 640 3.5 4.5
40–49 798 3.3 5.8 359 1.4 8.2 439 4.9 3.7
50–59 475 6.9 3.5 210 1.1 5.8 265 12 1.6
60–69 557 2.4 2.6 279 1.0 54 278 3.4 0.7
≥ 70 443 4.9 1.1 222 3.6 1.2 221 5.9 0.6
Mexican American
All 6,496 6.5 3.1 3,253 4.4 4.3 3,243 8.8 1.8
6–11 1,083 8.9 0 548 8.0 0.0 535 9.8 0.0
12–19 1,039 2.8 4.2 518 2.0 5.0 521 3.5 3.4
20–29 1,311 4.8 5.4 664 3.8 6.5 647 6.1 3.9
30–39 979 6.7 3.5 464 3.9 5.4 515 9.7 1.4
40–49 738 6.5 2.1 376 4.0 4.0 362 9.2 0.2
50–59 367 10 1.5 177 3.3 3.3 190 16 0.0
60–69 641 15 0.3 326 10 0.8 315 19 0.0
≥ 70 338 11 0.0 180 2.8 0.0 158 19 0.024-hr samples were costly and logistically
impractical to collect. Therefore, in keeping
with the most common approach in work-
place monitoring, spot urine samples were
collected and chemical measurements were
adjusted using creatinine. This approach was
generally considered the only valid way to
adjust spot urine samples for comparison
across groups, even though limited data were
available to evaluate the validity of this adjust-
ment. With the increase in the number of
child health studies in the 1990s, including
assessing in utero exposures by analyzing the
urine of pregnant women, the variation in
creatinine concentrations among different age
groups has become increasingly apparent.
Several researchers have noted signiﬁcant dif-
ferences in chemical exposures among chil-
dren and adults (Aprea et al. 2000; Heudorf
and Angerer 2001; Mills and Zahm 2001;
Wilder et al., unpublished data), and most
have recognized and reported that creatinine
adjustment elevates the urinary chemical con-
centrations in children compared with adults.
The differences between children and
adults are due partly to differences in lean mus-
cle mass. Children and the elderly tend to have
less muscle than active adults. Accordingly,
children have lower FFM than adults. Because
lean muscle produces the vast majority of
creatinine in the body, we evaluated the relation
between FFM and urinary creatinine. Indeed,
FFM and urinary creatinine were signiﬁcantly
associated (r = 0.222; p < 0.0001); however, the
magnitude of their correlation was much lower
than expected. When FFM is considered in the
linear regression model, it accounts for much,
but not all, of the signiﬁcant associations with
age, sex, and race. Because bioimpedance analy-
sis is not performed in most studies collecting
biomonitoring data for exposure assessments,
age, sex, and race can be used in concert as a
surrogate for FFM. Further, because the FFM
accounts for a signiﬁcant proportion of the vari-
ation of creatinine, creatinine-adjusted meas-
urements may serve as a useful surrogate for
estimating the size-related dose of an individual
(Barr et al. 2004).
Urinary biomonitoring measurements are
used to assess exposures of individuals and
population groups. For an individual, if the
urinary chemical level is divided by the creati-
nine concentration to adjust for dilution, one
must recognize that the urinary creatinine
concentration varies by age, sex, and race/
ethnicity (Mage et al. 2004). Therefore, it
would be best for “normal” or “reference”
ranges for creatinine-adjusted urinary levels to
be available for separate demographic groups,
(e.g., children, adolescents, and adults), rather
than just for the total population. The Second
National Report on Human Exposure to
Environmental Chemicals (National Center for
Environmental Health 2003) provides sepa-
rate reference ranges for 116 chemicals by age,
sex, and race/ethnicity. In addition, the report
provides reference ranges for non-creatinine-
adjusted levels.
For population groups, public health
scientists use the creatinine-adjusted urinary
chemical level in two types of models. In
model 1, the creatinine-adjusted urinary
chemical level is a dependent variable, and
other variables are regressed against it to deter-
mine signiﬁcant predictors of exposure to that
chemical. In model 2, the creatinine-adjusted
urinary chemical level is an independent vari-
able used to determine if that chemical expo-
sure is a significant predictor of a disease
outcome. In both models, the urinary chemi-
cal concentration is typically divided by the
urinary creatinine level, and the resulting con-
centration, expressed per weight of creatinine,
is the variable used.
In model 1, where the creatinine-corrected
urinary level is the dependent variable, inde-
pendent variables may be unrelated to the
chemical concentration itself but related to the
urinary creatinine concentration. In such a
case, the independent variable could poten-
tially achieve statistical significance only
because it is related to urinary creatinine.
Because age, sex, and race/ethnicity all relate
to urinary creatinine, this possibility would
have to be considered if they were signiﬁcant
predictors of creatinine-corrected urinary
chemical levels.
In model 2, a similar problem could exist
in which the creatinine-corrected urinary level
may be a signiﬁcant predictor of a health out-
come only because the health outcome is
related to urinary creatinine levels, not to the
levels of the chemical. This would be a less
likely scenario than model 1 but is possible
because the urinary level is a ratio of a chemi-
cal concentration divided by urinary creati-
nine concentration.
A straightforward solution to both of these
potential problems in interpreting multiple
regression results is to separate the urinary
chemical concentration from the urinary crea-
tinine concentration in the regression models.
For model 1, the dependent variable would be
the urinary chemical concentration, unad-
justed for creatinine. Urinary creatinine con-
centration would be included in the multiple
regression as an independent variable. In this
manner, the urinary chemical concentration is
adjusted for urinary creatinine, because uri-
nary creatinine is an independent variable, and
other covariates in the model are also adjusted
for urinary creatinine. Statistical significance
of independent variables would therefore not
be due to association with urinary creatinine
concentration.
Similarly, in model 2, urinary chemical
concentration (unadjusted for creatinine)
would be included with urinary creatinine as
independent variables to predict the health
outcome. The health outcome and the urinary
chemical concentration variables are adjusted
for creatinine by the urinary creatinine
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Table 5. Coefficients of the independent variables
from the multiple linear regression model of urinary
creatinine concentrations (dependent variable).
Independent variable
Variable Coefﬁcient ± SE p-Value
Intercept 53.51 ± 6.83 < 0.0001
Race/ethnicity
Non-Hispanic white (1) –7.33 ± 5.00 0.1486
Non-Hispanic black (2) 20.82 ± 5.68 0.0006
Mexican American (3) 0.00 ± 0.00 NA
Sex
Male (1) 34.59 ± 4.14 < 0.0001
Female (2) 0.00 ± 0.00 NA
Age group (years)
6–11 (1) 12.55 ± 5.24 0.0026
12–19 (2) 62.90 ± 5.64 < 0.0001
20–29 (3) 43.56 ± 5.70 < 0.0001
30–39 (4) 29.78 ± 5.78 < 0.0001
40–49 (5) 16.65 ± 6.42 0.0125
50–59 (6) –1.17 ± 6.24 0.8524
60–69 (7) –8.47 ± 4.81 0.0847
≥ 70 (8) 0.00 ± 0.00 NA
BMI (continuous) 1.30 ± 0.19 < 0.0001
Race/ethnicity × age group
(1) × (1) 16.19 ± 6.09 0.0106
(1) × (2) 16.14 ± 6.67 0.0192
(1) × (3) 10.74 ± 6.68 0.1141
(1) × (4) 4.34 ± 5.66 0.4469
(1) × (5) –2.40 ± 6.94 0.7308
(1) × (6) –0.82 ± 5.73 0.8864
(1) × (7) 6.99 ± 4.86 0.1569
(1) × (8) 0.00 ± 0.00 NA
(2) × (1) 8.64 ± 6.48 0.1886
(2) × (2) 24.28 ± 6.48 0.0005
(2) × (3) 28.19 ± 6.50 0.0001
(2) × (4) 15.01 ± 7.12 0.0403
(2) × (5) 14.69 ± 7.77 0.0648
(2) × (6) 14.98 ± 8.27 0.0762
(2) × (7) 8.58 ± 6.35 0.1826
(2) × (8) 0.00 ± 0.00 NA
(3) × (1) 0.00 ± 0.00 NA
(3) × (2) 0.00 ± 0.00 NA
(3) × (3) 0.00 ± 0.00 NA
(3) × (4) 0.00 ± 0.00 NA
(3) × (5) 0.00 ± 0.00 NA
(3) × (6) 0.00 ± 0.00 NA
(3) × (7) 0.00 ± 0.00 NA
(3) × (8) 0.00 ± 0.00 NA
Sex × age group
(1) × (1) –30.64 ± 4.26 < 0.0001
(1) × (2) –30.44 ± 5.86 < 0.0001
(1) × (3) 11.57 ± 5.30 0.0339
(1) × (4) 6.01 ± 7.16 0.4051
(1) × (5) 15.86 ± 5.53 0.0061
(1) × (6) 12.53 ± 7.57 0.1045
(1) × (7) 9.39 ± 5.51 0.0944
(1) × (8) 0.00 ± 0.00 NA
(2) × (1) 0.00 ± 0.00 NA
(2) × (2) 0.00 ± 0.00 NA
(2) × (3) 0.00 ± 0.00 NA
(2) × (4) 0.00 ± 0.00 NA
(2) × (5) 0.00 ± 0.00 NA
(2) × (6) 0.00 ± 0.00 NA
(2) × (7) 0.00 ± 0.00 NA
(2) × (8) 0.00 ± 0.00 NA
NA, not applicable. Numbers in parentheses correspond
to the specific racial/ethnic group, sex, or age group for
which the interaction term was derived.Article | Barr et al.
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independent variable, so any association of the
health outcome with chemical concentration
would not be inﬂuenced by a relationship with
urinary creatinine levels.
The present study has several limitations.
First, some of the variables used in our evalu-
ation of the data such as the bioimpedance
measurements and serum creatinine meas-
urements were available only for persons
> 12 years of age. Second, fasting times may
have differed among participants and no
dietary variables were considered in the analy-
sis. Third, children < 6 years of age were not
evaluated. Fourth, ﬁrst morning void samples
were not targeted for collection, so few were
likely present in our study; therefore, these
ﬁndings may not be directly applicable to ﬁrst
morning void samples. Last, upper-bound
conﬁdence intervals could not be established
for seven of the 90th-percentile estimates
given for creatinine levels in different age, sex,
and racial/ethnic demographic groups.
Conclusions
Generally, in epidemiologic studies it is not
practical to collect 24-hr urine samples or,
when young children are involved, even ﬁrst
morning voids. Therefore, spot samples are
generally the urine samples that are analyzed
for assessing human exposures to many chem-
icals. The urinary concentrations of these
chemicals are often reported on a weight/
volume basis and a creatinine-adjusted basis.
However, urinary creatinine concentrations
differ dramatically among different demo-
graphic groups; thus, biomonitoring studies
using creatinine concentrations to adjust the
concentrations of environmental and occupa-
tional chemical concentrations should seri-
ously consider the impact these ﬁndings will
have on the data. For an individual, the crea-
tinine-adjusted concentration of an analyte
should be compared with a “reference” range
derived from persons in a similar demo-
graphic group (e.g., children with children,
adults with adults). For multiple regression
analysis of population groups, we recommend
that the analyte concentration (unadjusted for
creatinine) be included in the multiple
regression analysis with urinary creatinine
added as a separate independent variable.
This approach allows the urinary analyte con-
centration to be appropriately adjusted for
urinary creatinine and the statistical signifi-
cance of other variables in the model (e.g.,
age, sex, race/ethnicity) to be independent of
effects of urinary creatinine concentration.
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